The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $40.35

Today's change+0.08 +0.20%
Updated January 20 4:01 PM EST. Delayed by at least 15 minutes.
 

Fresenius Medical Care AG & Co KGaA

NYSE: FMS
Last

(U.S.) $40.35

Today's change+0.08 +0.20%
Updated January 20 4:01 PM EST. Delayed by at least 15 minutes.

Fresenius Medical Care AG & Co KGaA up (U.S.)$0.08

Fresenius Medical Care AG & Co KGaA closed up Friday by (U.S.)$0.08 or 0.20% to (U.S.)$40.35. Shares have lost 0.74% over the last five days, but are unchanged over the last 52 weeks. This security has underperformed the S&P 500 by 20.01% during the last year.

Key company metrics

  • Open(U.S.) $40.41
  • Previous close(U.S.) $40.27
  • High(U.S.) $40.49
  • Low(U.S.) $40.27
  • Bid / Ask-- / --
  • YTD % change-4.41%
  • Volume196,081
  • Average volume (10-day)203,983
  • Average volume (1-month)182,838
  • Average volume (3-month)173,956
  • 52-week range(U.S.) $38.05 to (U.S.) $47.52
  • Beta0.54
  • Trailing P/E21.04×
  • P/E 1 year forward19.94×
  • Forward PEG2.37×
  • Indicated annual dividend(U.S.) $0.45
  • Dividend yield1.12%
  • Trailing EPS(U.S.) $1.92
Updated January 20 4:01 PM EST. Delayed by at least 15 minutes.
S&P TSX0.90%Sector:Industry:

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue4,5984,4204,2054,348
Total other revenue--------
Total revenue4,5984,4204,2054,348
Gross profit1,4721,3991,3181,468
Total cost of revenue3,1273,0222,8882,879
Total operating expense3,9283,7793,6653,686
Selling / general / administrative791729785788
Research & development44393740
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income670641540662
Interest income (expense), net non-operating-110-120-116-125
Gain (loss) on sale of assets--------
Other--------
Income before tax570539435574
Income after tax406370297393
Income tax, total164168138180
Net income333294228317
Total adjustments to net income--------
Net income before extra. items333294228317
Minority interest-73-76-69-77
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items333294228317
Inc. avail. to common incl. extra. items333294228317
Diluted net income333294228317
Dilution adjustment000--
Diluted weighted average shares307306306304
Diluted EPS excluding extraordinary itemsvalue per share1.090.960.751.04
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.090.960.751.04